Video

Barbara Van Husen on Improvements in MPN Research

Barbara Van Husen, president of the MPN Research Foundation, discusses how after the discovery of the JAK2 mutation in 2005, MPN research and treatment advances proliferated. Now, Van Husen says, it is one of the most active areas of hematological research

Barbara Van Husen, president of the MPN Research Foundation, discusses how after the discovery of the JAK2 mutation in 2005, MPN research and treatment advances proliferated. Now, Van Husen says, it is one of the most active areas of hematological research.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.
Image of doctor.
Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease.
There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.
Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
Image of woman.
Image of woman.
Image of woman.
Related Content